Li Yanqiu, Qiao Zihang, Li Jinze, Zhu Bingbing, Lu Yu, Feng Ying, Wang Xianbo
Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Clin Exp Med. 2025 Jul 28;25(1):265. doi: 10.1007/s10238-025-01813-w.
Patients with compensated advanced chronic liver disease (cACLD) have a significant risk of decompensation. Therefore, this study aimed to evaluate the predictive value of dynamic liver stiffness measurements (LSM) for decompensation risk, and their performance across different clinically significant portal hypertension (CSPH) risk stratification. This retrospective cohort study included 1409 patients with cACLD. Patients were divided into no CSPH, probable CSPH, and certain CSPH groups. Competing risk regression analysis was used to identify the independent predictors. The receiver operating characteristic curve and time-dependent area under the curve were used to evaluate the predictive performance. During follow-up, liver decompensation incidence increased with CSPH severity (22.2% with no CSPH, 37.5% with probable CSPH, and 64.9% with certain CSPH, p < 0.001). Multivariate regression analysis identified age, basal LSM1, delta LSM/LSM1, delta LSM/delta year, spleen diameter, and international normalized ratio as independent risk factors for liver decompensation. In the no CSPH group, spleen diameter showed the best predictive ability (AUC = 0.710). For probable and certain CSPH groups, delta LSM/LSM1 showed superior predictive performance (AUC: 0.777 and 0.782, respectively). The predictive power of basal LSM1 was relatively limited across all groups (AUC: 0.554-0.639). Subgroup analysis revealed interactions between age, sex, different etiologies, and CSPH subgroups. The relative change rate of LSM outperformed basal LSM1 and annual change rate in predicting liver decompensation risk, particularly in patients with existing portal hypertension. Dynamic assessments and differentiated prediction strategies are essential for optimal patient managements.
代偿期晚期慢性肝病(cACLD)患者有显著的失代偿风险。因此,本研究旨在评估动态肝脏硬度测量(LSM)对失代偿风险的预测价值,及其在不同临床显著门静脉高压(CSPH)风险分层中的表现。这项回顾性队列研究纳入了1409例cACLD患者。患者被分为无CSPH、可能有CSPH和确定有CSPH组。采用竞争风险回归分析来确定独立预测因素。采用受试者工作特征曲线和曲线下时间依赖性面积来评估预测性能。在随访期间,肝脏失代偿发生率随CSPH严重程度增加(无CSPH者为22.2%,可能有CSPH者为37.5%,确定有CSPH者为64.9%,p<0.001)。多变量回归分析确定年龄、基础LSM1、LSM变化率/LSM1、LSM变化率/年变化率、脾直径和国际标准化比值为肝脏失代偿的独立危险因素。在无CSPH组中,脾直径显示出最佳预测能力(AUC=0.710)。对于可能有CSPH和确定有CSPH组,LSM变化率/LSM1显示出更好的预测性能(AUC分别为0.777和0.782)。基础LSM1在所有组中的预测能力相对有限(AUC:0.554-0.639)。亚组分析揭示了年龄、性别、不同病因和CSPH亚组之间的相互作用。LSM的相对变化率在预测肝脏失代偿风险方面优于基础LSM1和年变化率,特别是在已有门静脉高压的患者中。动态评估和差异化预测策略对于优化患者管理至关重要。